Tokyo Tape
Sign in
← Fuji Latex

Half-year report · Q2

5199.TEDINET S100UO35
Period2024-04-01 → 2024-09-30
Filed2024-11-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥3.6bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥7.5bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥3.9bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥135m2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥247m2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥120m2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥382m2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥240m2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥98m2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥238m2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥58m2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥290m2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥174m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥58m2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥174m2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥11.2bnat 2024-09-30Cons.Assets
Total assets¥11.3bnat 2024-03-31Cons.Assets
Total assets¥11.4bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥7.4bnat 2024-09-30Cons.Liabilities
Total liabilities¥7.5bnat 2024-03-31Cons.Liabilities
Net assets / equity¥3.8bnat 2024-09-30Cons.Net assets
Net assets / equity¥3.9bnat 2024-03-31Cons.Net assets
Net assets / equity¥3.7bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥1.9bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥1.7bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥1.5bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.4bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥1.4bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.6bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow¥201m2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥211m2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥153m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow¥53m2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥123m2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥53m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥90m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥347m2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥283m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥45.822024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥228.422023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥1372023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio34.1%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio34.1%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio32.6%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 26
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥227m
jpcrp040300-q2r_E01109-000Medical Equipmentreportable segmentrevenue2024-04-01 → 2024-09-30¥1.4bn
jpcrp040300-q2r_E01109-000Medical Equipmentreportable segmentrevenue external2024-04-01 → 2024-09-30¥1.4bn
jpcrp040300-q2r_E01109-000Medical Equipmentreportable segmentsegment profit2024-04-01 → 2024-09-30¥70m
jpcrp040300-q2r_E01109-000Precision Equipmentreportable segmentrevenue2024-04-01 → 2024-09-30¥1.9bn
jpcrp040300-q2r_E01109-000Precision Equipmentreportable segmentrevenue external2024-04-01 → 2024-09-30¥1.9bn
jpcrp040300-q2r_E01109-000Precision Equipmentreportable segmentsegment profit2024-04-01 → 2024-09-30¥309m
jpcrp040300-q2r_E01109-000SPreportable segmentrevenue2024-04-01 → 2024-09-30¥224m
jpcrp040300-q2r_E01109-000SPreportable segmentrevenue external2024-04-01 → 2024-09-30¥224m
jpcrp040300-q2r_E01109-000SPreportable segmentsegment profit2024-04-01 → 2024-09-30−¥5m
—segment totalrevenue2024-04-01 → 2024-09-30¥3.6bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥3.6bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥362m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥239m
jpcrp040300-q2r_E01109-000Medical Equipmentreportable segmentrevenue2023-04-01 → 2023-09-30¥1.2bn
jpcrp040300-q2r_E01109-000Medical Equipmentreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.2bn
jpcrp040300-q2r_E01109-000Medical Equipmentreportable segmentsegment profit2023-04-01 → 2023-09-30−¥2m
jpcrp040300-q2r_E01109-000Precision Equipmentreportable segmentrevenue2023-04-01 → 2023-09-30¥2.1bn
jpcrp040300-q2r_E01109-000Precision Equipmentreportable segmentrevenue external2023-04-01 → 2023-09-30¥2.1bn
jpcrp040300-q2r_E01109-000Precision Equipmentreportable segmentsegment profit2023-04-01 → 2023-09-30¥459m
jpcrp040300-q2r_E01109-000SPreportable segmentrevenue2023-04-01 → 2023-09-30¥397m
jpcrp040300-q2r_E01109-000SPreportable segmentrevenue external2023-04-01 → 2023-09-30¥397m
jpcrp040300-q2r_E01109-000SPreportable segmentsegment profit2023-04-01 → 2023-09-30¥13m
—segment totalrevenue2023-04-01 → 2023-09-30¥3.9bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥3.9bn
—segment totalsegment profit2023-04-01 → 2023-09-30¥486m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 511
ItemContextValueUnit
Noncurrent liabilitiesPrior1YearInstant2649876000JPY
Noncurrent liabilitiesCurrentQuarterInstant2452894000JPY
LiabilitiesPrior1YearInstant7469007000JPY
LiabilitiesCurrentQuarterInstant7358985000JPY
Capital stockPrior1YearInstant643099000JPY
Capital stockCurrentQuarterInstant643099000JPY
Capital surplusPrior1YearInstant248362000JPY
Capital surplusCurrentQuarterInstant248362000JPY
Retained earningsPrior1YearInstant2532876000JPY
Retained earningsCurrentQuarterInstant2527581000JPY
Treasury stockPrior1YearInstant-41134000JPY
Treasury stockCurrentQuarterInstant-41472000JPY
Shareholders equityPrior1YearInstant3383204000JPY
Shareholders equityCurrentQuarterInstant3377572000JPY
Valuation difference on available for sale securitiesPrior1YearInstant145789000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant91049000JPY
Revaluation reserve for landPrior1YearInstant288295000JPY
Revaluation reserve for landCurrentQuarterInstant288295000JPY
Foreign currency translation adjustmentPrior1YearInstant34060000JPY
Foreign currency translation adjustmentCurrentQuarterInstant50560000JPY
Remeasurements of defined benefit plansPrior1YearInstant6258000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant5377000JPY
Valuation and translation adjustmentsPrior1YearInstant474404000JPY
Valuation and translation adjustmentsCurrentQuarterInstant435282000JPY
Net assetsPrior1YearInstant3857608000JPY
Net assetsCurrentQuarterInstant3812854000JPY
Liabilities and net assetsPrior1YearInstant11326615000JPY
Liabilities and net assetsCurrentQuarterInstant11171840000JPY
Net salesPrior1YTDDuration3866268000JPY
Net salesCurrentYTDDuration3639829000JPY
Cost of salesPrior1YTDDuration2929870000JPY
Cost of salesCurrentYTDDuration2853019000JPY
Gross profitPrior1YTDDuration936397000JPY
Gross profitCurrentYTDDuration786810000JPY
Selling general and administrative expensesPrior1YTDDuration688958000JPY
Selling general and administrative expensesCurrentYTDDuration651828000JPY
Operating incomePrior1YTDDuration247439000JPY
Operating incomeCurrentYTDDuration134982000JPY
Interest income noiPrior1YTDDuration200000JPY
Interest income noiCurrentYTDDuration255000JPY
Dividends income noiPrior1YTDDuration5259000JPY
Dividends income noiCurrentYTDDuration5781000JPY
Rent income noiPrior1YTDDuration6798000JPY
Rent income noiCurrentYTDDuration6798000JPY
Subsidy income noiPrior1YTDDuration17025000JPY
Subsidy income noiCurrentYTDDuration10000000JPY
Other noiPrior1YTDDuration2670000JPY
Other noiCurrentYTDDuration4669000JPY
Non operating incomePrior1YTDDuration31954000JPY
Non operating incomeCurrentYTDDuration27505000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass
balance sheet identityconsolidated 2024-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass